Analysis of drug sensitivity of human high-grade osteosarcoma in a chick chorioallantoic membrane (CAM) model: a proof of principle study:
Abstract
Objective
Multi-agent chemotherapy is an important pillar in treatment of high-grade osteosarcoma. In an effort to improve patient survival, it is imperative to determine the effectiveness of new substances. The objective of this study was to investigate whether the chick chorioallantoic membrane (CAM) model can be used to analyze drug sensitivity in high-grade osteosarcoma.
Results
Spare biopsy tissue from five patients diagnosed with high-grade osteosarcoma was transferred into non-immortalized primary cell culture. After a pre-incubation period of 10 days, fertilized chick eggs were inoculated with primary tumor cells suspended in extracellular matrix gel. On day 16, treatment with 20 µmol/l doxorubicin (n = 4) or 25 µl of culture medium (n = 6) was performed for 24 h. CAM membranes were documented macroscopically, harvested and examined histologically. Transfer of biopsy specimens into primary cell culture was successful in all cases. 50% (n = 10) of eggs died after inoculation with tumor cells and before application of doxorubicin. No deaths occurred after application of doxorubicin. Histological examination found a response to doxorubicin in all four specimens. Based upon these results, the CAM model represents a promising preclinical alternative to animal experiments to determine drug sensitivity of osteosarcoma cells. Further research with regard to other substances and dosages appear justified.
Background
High-grade osteosarcoma is a rare disease, mostly affecting children, adolescents and young adults. A combination of chemotherapy and wide tumor resection are the main pillars for successful treatment of these patients. The significance of chemotherapy becomes clear when considering how overall survival rates improved from 20% to more than 60% with the introduction of multi-agent chemotherapy [1]. Standard chemotherapeutic agents include doxorubicin, cisplatin, ifosfamide and methotrexate [2]. Patients are usually enrolled in multimodal clinical trials in an effort to improve treatment outcomes by comparing new approaches to a standard regimen. Current protocols intend patients to undergo neoadjuvant chemotherapy to evaluate response to chemotherapy as the percentage of tumor regression found in the resection specimen of the primary tumor. As a result, good and poor responders are assigned to different adjuvant chemotherapy groups, which vary with regard to duration and composition of remaining treatments [2]. However, evidence regarding the efficacy of this risk-stratified treatment approach is still lacking [3, 4]. Therefore, in case of poor response to chemotherapy, an antedated operation or modulation of administered chemotherapy might be desirable. However, no significant developments have been made with regard to new drugs in osteosarcoma protocols over the last few decades which may also be due to the lack of suitable preclinical individualized models having the power to reliably predict response [1, 3, 4].
Preclinical research currently relies on in vitro and mouse models for drug screens to identify promising substances that might be translated into a clinical trial [5]. The latter in vivo xenograft models tend to be lengthy and unable to yield short-term information that might be able to influence individual treatment approaches. Beyond that, there has been a paradigm shift in our scientific society: ethical recommendations challenge scientists to develop models that do not rely on animal experiments whenever possible. In this context, the chorioallantoic membrane (CAM) model is particularly interesting as the chick embryo is not considered to be a living animal until day 17 of development in most countries and therefore does not fall under animal experiment [6, 7]. Though successful engraftment of musculoskeletal tumors including human osteosarcoma cell lines has been reported and though there is some preliminary evidence that it may serve as a preclinical screening assay predictive for disease outcome, it is not in common use yet [8, 9].
Therefore, it is the objective of this study to analyze whether the CAM model may serve as a reliable preclinical drug-screening assay and if so, may even be predictive of response of the tumor to chemotherapy seen in the resected specimen of the primary tumor in a follow-up study.
Αρχειοθήκη ιστολογίου
-
►
2023
(138)
- ► Φεβρουαρίου (74)
- ► Ιανουαρίου (64)
-
►
2022
(849)
- ► Δεκεμβρίου (61)
- ► Σεπτεμβρίου (74)
- ► Φεβρουαρίου (65)
-
►
2021
(2936)
- ► Δεκεμβρίου (59)
- ► Σεπτεμβρίου (180)
- ► Φεβρουαρίου (325)
-
▼
2020
(1624)
- ► Δεκεμβρίου (293)
-
▼
Σεπτεμβρίου
(234)
-
▼
Σεπ 16
(91)
- Medicine by Alexandros G. Sfakianakis
- IJERPH, Vol. 17, Pag
- Humanities, Vol. 9, Pages 113: The Historical Lan...
- IJERPH, Vol. 17, Pag
- HER2-positive human breast carcinoma SK-BR-3 cel...
- heory of COVID-19 pathogenesisPublication date: N...
- Non-invasive assessment of endothelial dysfunction...
- antibodies targeting modified ribonucleotides [MET...
- buccal mucoadhesive films for photodynamic inactiv...
- Improved Antimicrobial Properties of Methylene Blu...
- Efficacy of aminolevulinic acid 20% solution combi...
- Microelectrode Recording and Radiofrequency Thalam...
- Percutaneous Foramen Ovale Puncture: Usefulness of...
- Circumferential Subannular Tympanoplasty: Panacea ...
- Paleontology: The oldest known sperm cells
- Proprioception but not cardiac interoception is re...
- A Pandemic within a Pandemic — Intimate Partner Vi...
- Fecal Microbiome Alteration May Be a Potential Mar...
- Dosimetric feasibility of hypofractionation for SB...
- Pancreatic ascites managed with a conservative app...
- A rare case of multisystemic langerhans cell histi...
- Erosive pustular dermatosis after CO2 Laser resurf...
- Gamma Knife Radiosurgery as a Primary Treatment fo...
- Comparison of autologous platelet-rich plasma and ...
- Cutaneous squamous cell carcinoma presenting with ...
- Dyskeratosis congenita: reticulate hyperpigmentat...
- Primary, Secondary, and Tertiary Effects of Carboh...
- Effects of Cold Atmospheric Pressure Plasma and Di...
- Laser‐assisted nucleic acid delivery
- Analysis of drug sensitivity of human high-grade o...
- CD8+ T Cell Infiltration Predicts Chemoradiosensit...
- Cellular and molecular mechanisms in fibrosis
- MicroRNA-92a Inhibits the Cell Viability and Metas...
- Determining the significance of psammoma bodies in...
- Fine needle aspiration cytomorphology of papillary...
- The Paris System for reporting urinary cytology
- Loeys‐Dietz syndrome (LDS), a connective tissue di...
- Totally Robotic Caudate Lobe Liver Resection
- Effects of nerve‐sparing procedures on bowel funct...
- negative automatic thoughts
- Deregulated immune cell recruitment orchestrated b...
- mutational signatures in head and neck cancer
- Reasons behind the rapid increase of thyroid cance...
- Optimal management of esophageal cancer
- Nintedanib plus mFOLFOX6 as second‐line treatment ...
- Polygenic hazard score (PHS) models are associated...
- Nasopharyngeal Carcinoma in Children and Adolescents
- Overdiagnosis in lung cancer screening
- Value of upper GI endoscopy for gastric cancer sur...
- Prophylaxis of Post-Inflammatory Hyperpigmentation...
- Management of an Imminent Pathological Fracture of...
- preoperative microvessel evaluation and characteri...
- Galectin-3 not Galectin-9 as a candidate prognosis...
- Neuromodulation in Psychiatric disorders: Experime...
- Cortical responses to whole‐body balance perturbat...
- Modulation of binocular rivalry with rapid monocul...
- chitinase‐3‐like protein 1 in recurrence patterns ...
- Lungs Infected With Sars‐Cov 2.......Immunohistoch...
- Functional Communication Profiles of Children and ...
- Perirolandic atrophy occurs in corticobasal syndro...
- Fear of Cancer Recurrence in Patients with Multipl...
- electronic psychosocial screening in pediatric onc...
- losatuxizumab vedotin (ABBV-221), an anti-EGFR ant...
- Intratumoral submicron particle docetaxel inhibits...
- Novel Bacillus strains from the human gut exert an...
- adjuvant trastuzumab on locoregional failure rates
- carbon‐ion radiotherapy for patients with locoregi...
- Association between postoperative complications an...
- Hyperthermic intraperitoneal chemotherapy in inter...
- 5-ALA-mediated photodynamic therapy on oral squamo...
- Early fiberoptic endoscopic evaluation of swallow ...
- Transoral robotic parapharyngeal approach to the s...
- nodal and distant metastases in sinonasal adenocar...
- Pediatric Rigid Bronchoscopy for Tracheobronchial ...
- Iodine Concentration in Dual-Energy Computed Tomog...
- MRI Techniques for Imaging Blood-Brain Barrier Int...
- Fusion of Preinterventional MR Imaging With Liver ...
- CT Dosimetry: What Has Been Achieved and What Rema...
- A Magnetic Resonance Imaging Radiomics Signature t...
- Left heart bypass versus circulatory arrest for op...
- Systematic review of perioperative mortality risk ...
- Gene signatures from scRNA‐seq accurately quantify...
- Acute Cholecystitis during Lenvatinib for Advanced...
- Insulin‐induced amyloidoma—A cytological catch
- Low Diagnostic Yield of Repeat Blood Cultures in A...
- Biallelic intronic AAGGG expansion of RFC1 is rela...
- Positive selection within the genomes of SARS-CoV-...
- The tumour immune landscape and its implications i...
- Medicine by Alexandros G. Sfakianakis
-
▼
Σεπ 16
(91)
- ► Φεβρουαρίου (28)
-
►
2019
(13362)
- ► Δεκεμβρίου (19)
- ► Σεπτεμβρίου (54)
- ► Φεβρουαρίου (5586)
- ► Ιανουαρίου (5696)
-
►
2018
(66471)
- ► Δεκεμβρίου (5242)
- ► Σεπτεμβρίου (5478)
- ► Φεβρουαρίου (4835)
- ► Ιανουαρίου (5592)
-
►
2017
(44259)
- ► Δεκεμβρίου (5110)
- ► Σεπτεμβρίου (5105)
-
►
2016
(7467)
- ► Δεκεμβρίου (514)
- ► Σεπτεμβρίου (1038)
- ► Φεβρουαρίου (793)
Αναζήτηση αυτού του ιστολογίου
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Αλέξανδρος Γ. Σφακιανάκης Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,0030693260717...
-
heory of COVID-19 pathogenesis Publication date: November 2020Source: Medical Hypotheses, Volume 144Author(s): Yuichiro J. Suzuki ScienceD...
-
Alimentary Pharmacology &Therapeutics, EarlyView. https://ift.tt/2qECBIJ
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.